Chemed Corp (NYSE:CHE) — Market Cap & Net Worth
Market Cap & Net Worth: Chemed Corp (CHE)
Chemed Corp (NYSE:CHE) has a market capitalization of $6.16 Billion ($6.16 Billion) as of June 22, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #3169 globally and #1111 in its home market, demonstrating a 0.43% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Chemed Corp's stock price $436.27 by its total outstanding shares 14108915 (14.11 Million). Review CHE total debt and obligations to assess the company's total debt and financial obligations.
Chemed Corp Market Cap History: 2015 to 2026
Chemed Corp's market capitalization history from 2015 to 2026. Data shows growth from $2.04 Billion to $6.16 Billion (12.13% CAGR).
Index Memberships
Chemed Corp is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P Midcap 400
MID
|
$3.53 Trillion | 0.35% | #230 of 401 |
Weight: Chemed Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Chemed Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Chemed Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.07x
Chemed Corp's market cap is 3.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
24.75x
Chemed Corp's market cap is 24.75 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.04 Billion | $1.54 Billion | $110.27 Million | 1.32x | 18.51x |
| 2016 | $2.20 Billion | $1.58 Billion | $108.74 Million | 1.40x | 20.25x |
| 2017 | $3.35 Billion | $1.67 Billion | $98.18 Million | 2.01x | 34.16x |
| 2018 | $3.92 Billion | $1.78 Billion | $205.54 Million | 2.20x | 19.09x |
| 2019 | $6.11 Billion | $1.94 Billion | $219.92 Million | 3.15x | 27.76x |
| 2020 | $7.42 Billion | $2.08 Billion | $319.47 Million | 3.57x | 23.24x |
| 2021 | $7.40 Billion | $2.14 Billion | $268.55 Million | 3.46x | 27.54x |
| 2022 | $7.16 Billion | $2.13 Billion | $249.62 Million | 3.35x | 28.67x |
| 2023 | $8.22 Billion | $2.26 Billion | $272.51 Million | 3.63x | 30.18x |
| 2024 | $7.47 Billion | $2.43 Billion | $302.00 Million | 3.07x | 24.75x |
Competitor Companies of CHE by Market Capitalization
Companies near Chemed Corp in the global market cap rankings as of June 22, 2026.
Key companies related to Chemed Corp by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #320 globally with a market cap of $80.16 Billion USD.
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #995 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #1029 globally with a market cap of $26.08 Billion USD ( €22.31 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1332 globally with a market cap of $19.52 Billion USD ( RM77.76 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #320 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $375.17 |
| #995 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1029 | Fresenius SE & Co. KGaA | XETRA:FRE | $26.08 Billion | €39.61 |
| #1332 | IHH Healthcare Bhd | KLSE:5225 | $19.52 Billion | RM8.80 |
Chemed Corp Historical Marketcap From 2015 to 2026
Between 2015 and today, Chemed Corp's market cap moved from $2.04 Billion to $ 6.16 Billion, with a yearly change of 12.13%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $6.16 Billion | +1.97% |
| 2025 | $6.04 Billion | -19.24% |
| 2024 | $7.47 Billion | -9.11% |
| 2023 | $8.22 Billion | +14.90% |
| 2022 | $7.16 Billion | -3.22% |
| 2021 | $7.40 Billion | -0.38% |
| 2020 | $7.42 Billion | +21.59% |
| 2019 | $6.11 Billion | +55.58% |
| 2018 | $3.92 Billion | +17.01% |
| 2017 | $3.35 Billion | +52.32% |
| 2016 | $2.20 Billion | +7.89% |
| 2015 | $2.04 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 22nd, 2026 the market cap of Chemed Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.16 Billion USD |
| MoneyControl | $6.16 Billion USD |
| MarketWatch | $6.16 Billion USD |
| marketcap.company | $6.16 Billion USD |
| Reuters | $6.16 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commer… Read more